About Dual AAV
Dual AAV vectors split your gene into two vectors that under in-vivo homologous recombination, reforms to produce a full gene product. These are used when payloads >4.7kb are required.
Dual AAV vector controls contain two AAV vectors, with each vector carrying half of a GFP reporter gene. When recombined, a functional GFP is formed, allowing quick visual read-out.
Your team can use dual AAV vector controls to de-risk projects, for proof-of-principle studies, and to optimize parameters before moving into larger, more complex experiments. These controls are available in a wide range of promoters for tissue targeting.
Features
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
· >95% Purity
· Low endotoxin (<0.3 EU/ml)
· Whole plasmid sequencing
· Dedicated technical support
Benefits
· Efficient delivery of large genes >4.7kb
AAV-h-ARRDC1-shRNA
Cat No: shAAV-201478
Availability: 4-5 weeks
AAV-h-ARRDC2-shRNA
Cat No: shAAV-201479
Availability: 6-8 weeks
AAV-h-ARRDC3-shRNA
Cat No: shAAV-201480
Availability: 4-5 weeks
AAV-h-ARRDC4-shRNA
Cat No: shAAV-201482
Availability: 6-8 weeks
AAV-h-ARSA-shRNA
Cat No: shAAV-201484
Availability: 6-8 weeks
AAV-h-ARSB-shRNA
Cat No: shAAV-201485
Availability: 4-5 weeks
AAV-h-ARSE-shRNA
Cat No: shAAV-201486
Availability: 6-8 weeks
AAV-h-ARSF-shRNA
Cat No: shAAV-201487
Availability: 6-8 weeks
AAV-h-ARSG-shRNA
Cat No: shAAV-201488
Availability: 6-8 weeks
AAV-h-ARSH-shRNA
Cat No: shAAV-201490
Availability: 6-8 weeks
AAV-h-ARSI-shRNA
Cat No: shAAV-201491
Availability: 6-8 weeks
AAV-h-ARSJ-shRNA
Cat No: shAAV-201493
Availability: 4-5 weeks
